Congressional Myopia in Biomedical Innovation Policy
All Jotwell content is available under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License. The Attribution-Noncommercial Share Alike License allows others to use and modify Jotwell materials for noncommercial purposes, as long as they acknowledge Jotwell and the author of the contribution as the source of their material.
Abstract
Innovation policy is hard. Getting it right requires balancing incentives for developers, consumer access, rewards for later innovators, safety concerns, and other factors. This balance is vitally important and wickedly difficult—even when it’s the focus of concerted, careful, informed effort. How well should we expect it to go when innovation policy is made by accident?
This paper has been withdrawn.